| ²é¿´: 2589 | »Ø¸´: 41 | |||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û38´Î£¬×÷ÕßΩ¾«Î©Ò»Ôö¼Ó½ð±Ò 29.8 ¸ö | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[×ÊÔ´]
»ùÓÚAKT¼¤Ã¸µÄ¿¹Ö×ÁöÒ©ÎïÑо¿
|
|||
|
ÒýÑÔ ¼¤Ã¸À࿹Ö×ÁöÒ©ÎïÔÚÒ©ÎﻯѧÁìÓòÕ¼Óзdz£ÖØÒªµÄµØÎ»£¬Òò´Ë²»¶®¼¤Ã¸Ò©Îï¾Í²»ËãÒ»¸öÕæÕýµÄÒ©»¯¹¤×÷Õß¡£ÒÔÏÂÊDZ¾×ÛÊöµÄÄÚÈÝÌá¸Ù Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting I. Introduction II. Historical Perspective III. Structure of AKTs IV. AKT Activation During Signal Transduction V. Crystal Structure of AKT Kinases VI. Substrates of AKT Mediating its Cellular Functions A. Cell Proliferation B. Cell Survival C. Metabolism D. Cell Growth/Translation/Response to Nutrients E. Other Oncogenic Functions of AKT Signaling VII. AKT Alterations in Human Cancers A. AKT Amplification and Overexpression B. AKT Activation in Human Tumors VIII. Alterations of Other Components of the PI3K/AKT Pathway in Human Cancers A. PI3K B. PTEN C. TSC2 D. eIF4E IX. In Vivo Models of AKT Activation X. Implications of AKT Pathway Activation for Therapeutic Targeting A. Rationale for Targeting the AKT Pathway for New Drug Discovery Efforts B. Role of AKT in the Therapeutic Response of Tumor Cells C. Molecular Targets in the AKT Signaling Pathway D. Targeting AKT Kinases E. Targeting mTOR F. Liabilities Associated with Targeting the AKT Signaling Pathway XI. Conclusions Acknowledgments References |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ActivationofAKTKinasesin.pdf
2012-12-30 15:18:01, 759 K
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ÌÔÌù |
» ²ÂÄãϲ»¶
ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O54,¿ÆÄ¿È«,¿ÉÙ¤¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O54,¿ÆÄ¿È«,¿ÉÙ¤¼±
ÒѾÓÐ4È˻ظ´
ÊÛÒ»ÇøSCIÎÄÕÂT0P£¬ÎÒ:8O.551.O54,¿ÆÄ¿È«,¿ÉÊ®¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿ÉÙ¤¼±
ÒѾÓÐ7È˻ظ´
ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿
ÒѾÓÐ18È˻ظ´
ÊÛSCIÎÄÕ£¬ÎÒ:8O5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCI-T0PÎÄÕ£¬ÎÒ:8O.5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ7È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿ÉÙ¤¼±
ÒѾÓÐ8È˻ظ´
¹ú×ÔÈ»ÆÀÉóÒâ¼û
ÒѾÓÐ17È˻ظ´
ÎÒ¾ÍÊÇÉêÇëÒ»¸öÃæÉÏÏîÄ¿¶øÒÑ£¬ÕâÆÀÉóÒâ¼ûÊǰ´ÕÕ½ÜÇàµÄÌõ¼þÆÀµÄ°É£¿
ÒѾÓÐ8È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÎÒ¹ú¡°ÌæÄáÀࡱ£¨ÀÒ°±ËἤøÒÖÖÆ¼Á£©¿¹Ö×ÁöÒ©µÄÊг¡ÏÖ×´
ÒѾÓÐ15È˻ظ´
16Â¥2013-01-05 13:06:13
¼òµ¥»Ø¸´
guoxq19722Â¥
2012-12-30 22:30
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2012-12-30 23:53
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
luzhuolin5Â¥
2012-12-31 08:18
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
cxgxb6Â¥
2012-12-31 10:00
»Ø¸´
ÈýÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
pufanlg7Â¥
2012-12-31 11:29
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wintheone8Â¥
2012-12-31 13:43
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
erickin9Â¥
2012-12-31 16:20
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
tcmtc10Â¥
2012-12-31 18:09
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
Chengxm11Â¥
2012-12-31 20:21
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wgx112812Â¥
2013-01-01 16:55
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
yunnanyan13Â¥
2013-01-01 19:00
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡









»Ø¸´´ËÂ¥
·Ç³£¸Ðл
10